Comparison of Diabetes Patients - Care Trajectory Versus Convention
- Conditions
- Type 2 Diabetes
- Registration Number
- NCT06577584
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Brief Summary
In Belgium, various structures and reimbursement programs are in place for managing Type 2 Diabetes Mellitus (T2DM). The Diabetes Care Trajectory is primarily utilized for patients who require a maximum of two insulin injections per day. In contrast, patients needing multiple daily insulin injections are managed under a diabetes convention program.
The Diabetes Care Trajectory has been operational since 2009. However, unlike patients in the diabetes convention program, where the profile and quality of care are regularly audited, there is limited information available regarding the profile and outcomes of patients within the Care Trajectory. This retrospective study aims to compare the profiles, including complications and quality of care, of T2DM patients across both groups.
- Detailed Description
This retrospective study will collect data from T2DM patients enrolled in either the Diabetes Care Trajectory or the diabetes convention program. The data gathered will encompass quality of care, clinical status, complications, and metabolic state.
The profiles of these patient populations will be compared cross-sectionally for each year within the study period (2009-2024). Additionally, a longitudinal analysis will be conducted to examine the evolution of these profiles over the entire study period. Data will be extracted from electronic case records maintained at participating sites across Belgium.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 20000
- Followed in one of the NexusHealth hospitals in Belgium: https://www.nexuzhealth.com/en/why-nexuzhealth/patients/affiliated-healthcare-institutions
- Having being diagnosed with type 2 diabetes mellitus
- Followed in the Diabetes Care Trajectory or in the Diabetes Convention (group B) in Belgium
no specific exclusion criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c Yearly for the entire study period (2009 - 2024) Glycated haemoglobin A1c
- Secondary Outcome Measures
Name Time Method Insulin requirements Yearly for the entire study period (2009 - 2024) The need for insulin (units) on a daily basis
Complications of diabetes Yearly for the entire study period (2009 - 2024) Number of diabetes-associated complications such as retinopathy, nephropathy and macroangiopathy.
Cholesterol profile Yearly for the entire study period (2009 - 2024) Total levels of cholesterol